Mounjaro 12,5 mg 1 pen

Mounjaro 12,5 mg 1 pen

Composition:

Tirzepatide 12,5 mg per dose.
Excipients: solution for injection.

Product Description: 

Mounjaro is a prescription injectable solution formulated for subcutaneous use once weekly.
Tirzepatide is a dual GIP and GLP-1 receptor agonist that improves glycemic control in adults with type 2 diabetes and supports weight management. 

Indications for Use: 

Improves blood sugar control in type 2 diabetes, supports weight reduction, and enhances metabolic regulation. 

Method of Administration and Dosage: 

Inject subcutaneously once weekly using the pre-filled Pen.
Rotate injection sites (abdomen, thigh, upper arm).
Dosage adjusted by physician. 

Contraindications: 

Hypersensitivity to tirzepatide or excipients.
Not indicated for type 1 diabetes or diabetic ketoacidosis. 

Precautions: 

Use under medical supervision.
Monitor for gastrointestinal side effects and hypoglycemia when combined with insulin or sulfonylureas. 

Adverse Reactions (Side Effects): 

Nausea, vomiting, diarrhea, decreased appetite, possible injection site reactions. 

Pregnancy and Lactation: 

Not recommended; consult physician. 

Storage Conditions: 

Refrigerate at 2-8 °C. 
Do not freeze.
Protect from light. 

Packaging: 

Carton box containing 1 pre-filled pen (4 doses).